H

P

HEUDEL , Pierre‐etienne

Last name: HEUDEL

First name: Pierre‐etienne

December 15, 2019 (v1)

Journal article

Metadata-only

Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program

Jacot, William Heudel, Pierre‐etienne Fraisse, Julien

Eribulin mesylate (EM) was recently approved for metastatic breast cancer (MBC) chemotherapy (CT) in late lines by the FDA, with debated results in second line. We evaluated outcomes in breast cancer patients receiving EM as second, third and fourth line in a national real-life cohort of 16,703 consecutive MBC patients initiating their first...

Uploaded on: December 4, 2022